Back
BioXcel Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
BTAI
BioXcel Therapeutics, Inc.
Last Price:
$1.71
Seasonality Move:
59.54%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing slight buying pressure.
BioXcel Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.82 | Sell |
| 20-day SMA: | 1.97 | Sell |
| 50-day SMA: | 2.01 | Sell |
| 200-day SMA: | 2.31 | Sell |
| 8-day EMA: | 1.82 | Sell |
| 20-day EMA: | 1.91 | Sell |
| 50-day EMA: | 2.1 | Sell |
| 200-day EMA: | 4.47 | Sell |
BioXcel Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 38.87 | Sell |
| Chaikin Money Flow: | 119901 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.79 - 2.11) | Sell |
| Bollinger Bands (100): | (1.67 - 4.01) | Sell |
BioXcel Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics, Inc. Stock
Is BioXcel Therapeutics, Inc. Stock a Buy?
-
BioXcel Therapeutics, Inc. share price is 1.71 while BTAI 8-day simple moving average is 1.82, which is a Sell signal.
-
The stock price of BTAI is 1.71 while BioXcel Therapeutics, Inc. 20-day SMA is 1.97, which makes it a Sell.
-
BioXcel Therapeutics, Inc. 50-day simple moving average is 2.01 while BTAI share price is 1.71, making it a Sell technically.
-
BTAI stock price is 1.71 and BioXcel Therapeutics, Inc. 200-day simple moving average is 2.31, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
23
BioXcel Therapeutics, Inc. (BTAI)
is a Sell
Is BioXcel Therapeutics, Inc. a Buy or a Sell?
-
BioXcel Therapeutics, Inc. stock is rated a SellThe current BioXcel Therapeutics, Inc. [BTAI] share price is $1.71. The Score for BTAI is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics, Inc. Stock Info
Market Cap:
37.4M
Price in USD:
1.71
Share Volume:
308.7K
BioXcel Therapeutics, Inc. 52-Week Range
52-Week High:
9.26
52-Week Low:
1.17
Sell
23
BioXcel Therapeutics, Inc. (BTAI)
is a Sell
BioXcel Therapeutics, Inc. Share Price Forecast
-
What is the BioXcel Therapeutics, Inc. stock price today?The BioXcel Therapeutics, Inc. stock price is 1.71 USD today.
-
Will BTAI stock go up or go down?BioXcel Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is BioXcel Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics, Inc. is overvalued.
Is BioXcel Therapeutics, Inc. Stock a Buy?
-
BioXcel Therapeutics, Inc. share price is 1.71 while BTAI 8-day exponential moving average is 1.82, which is a Sell signal.
-
The stock price of BTAI is 1.71 while BioXcel Therapeutics, Inc. 20-day EMA is 1.91, which makes it a Sell.
-
BioXcel Therapeutics, Inc. 50-day exponential moving average is 2.10 while BTAI share price is 1.71, making it a Sell technically.
-
BTAI stock price is 1.71 and BioXcel Therapeutics, Inc. 200-day simple moving average is 4.47, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics, Inc.
Is BioXcel Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.68 per share, a decrease next quarter of $0.00 per share, an increase this year of $18.54 per share, and an increase next year of $3.74 per share.
Technical Analysis of BioXcel Therapeutics, Inc.
Should I short BioXcel Therapeutics, Inc. stock?
-
BTAI Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting BioXcel Therapeutics, Inc. is a Sell
-
BioXcel Therapeutics, Inc. Relative Strength Index (RSI) is 38.87, which suggest BioXcel Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for BioXcel Therapeutics, Inc. is (1.79 - 2.11), which suggest BioXcel Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for BioXcel Therapeutics, Inc. is (1.67 - 4.01), which suggest BioXcel Therapeutics, Inc. is a Sell
* BioXcel Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.